Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Ixekizumab> ?p ?o. }
Showing items 1 to 33 of
33
with 100 items per page.
- Ixekizumab abstract "Ixekizumab is a humanized monoclonal antibody for the treatment of autoimmune diseases. More specifically, it is being tested for the use in psoriasis. A Phase II clinical trial including patients with moderate to severe psoriasis has been completed, and a Phase III open-label trial is under way as of November 2013.Ixekizumab was developed by Eli Lilly and Co.".
- Ixekizumab atcPrefix "none".
- Ixekizumab casNumber "1143503-69-8".
- Ixekizumab wikiPageID "33024053".
- Ixekizumab wikiPageRevisionID "583936732".
- Ixekizumab atcPrefix "none".
- Ixekizumab c "6492".
- Ixekizumab casNumber "1143503".
- Ixekizumab chemspiderid "NA".
- Ixekizumab h "10012".
- Ixekizumab hasPhotoCollection Ixekizumab.
- Ixekizumab legalStatus "Investigational".
- Ixekizumab mabType "mab".
- Ixekizumab molecularWeight "146.2".
- Ixekizumab n "1728".
- Ixekizumab o "2028".
- Ixekizumab s "46".
- Ixekizumab source "zu".
- Ixekizumab target Interleukin_17.
- Ixekizumab type "mab".
- Ixekizumab verifiedfields "changed".
- Ixekizumab verifiedrevid "458270595".
- Ixekizumab subject Category:Eli_Lilly_and_Company.
- Ixekizumab type Drug.
- Ixekizumab type FunctionalSubstance.
- Ixekizumab comment "Ixekizumab is a humanized monoclonal antibody for the treatment of autoimmune diseases. More specifically, it is being tested for the use in psoriasis. A Phase II clinical trial including patients with moderate to severe psoriasis has been completed, and a Phase III open-label trial is under way as of November 2013.Ixekizumab was developed by Eli Lilly and Co.".
- Ixekizumab label "Ixekizumab".
- Ixekizumab label "إيكسيكيزوماب".
- Ixekizumab sameAs m.0h53clz.
- Ixekizumab sameAs Q13574436.
- Ixekizumab sameAs Q13574436.
- Ixekizumab wasDerivedFrom Ixekizumab?oldid=583936732.
- Ixekizumab isPrimaryTopicOf Ixekizumab.